| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.03 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |